Crusade Risk Score for ACS
Not in any tracked top chart right now.
Updated 25 Oct 2026 · rankings refresh through the day
DeveloperPutu Angga Risky Raharja
CategoryMedical
PriceFree
Released
Rating★ 5.0 (4)
Version3.1
Age rating12+
First seen by us
24 Oct 2026
Rating
5.0 ★
4 ratings
Measured
Crusade Risk Score for ACS on the App Store
App details
App ID
1241597068
Publisher
Putu Angga Risky Raharja
On the store since
May 2017
9 years on the store
Minimum OS
iOS 12.0+
iPhone 5s and later
Devices
iPhone · iPad
Universal purchase
Content rating
12+
1 content note below
Languages
1
EN
Size
38 MB
Also listed in
Health & Fitness
Content notesInfrequent/Mild Medical/Treatment Information
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
5.0 ★
4 ratings
Measured
Ratings
4
Measured
About Crusade Risk Score for ACS
Coronary heart disease (CHD) is one of the most important leading causes of death in the whole world. Among the different clinical presentations of Coronary heart disease (CHD), acute coronary syndrome (ACS) is the most important and life threatening condition. In spite of their obvious effect, antithrombotic therapies for acute coronary syndrome (ACS) significantly increase bleeding. Hence, it is important to predict the bleeding risk in acute coronary syndrome (ACS) patients in order to modify their treatment aiming to reduce their bleeding events and improve their outcome. "CRUSADE Risk Score for ACS: Cardiology Calculator" apps will help to stratify bleeding risk in acute coronary syndrome (ACS) patients with CRUSADE score.
Why should you choose "CRUSADE Risk Score for ACS: Cardiology Calculator"?
- Simple and very easy to use.
- Define the importance of CRUSADE bleeding risk stratification
- Accurately scoring all the variables needed
- Thorough interpretation of the bleeding risk for every patient
- Calculates not only the risk of major bleeding in general non-ST elevation acute coronary syndrome (NSTE-ACS) patients but also the relation to the number of anti-thrombotics used and the relation to the treatment approach (whether it will be conservative or interventional)
- It is totally free. Download now!
CRUSADE Risk Score for acute coronary syndrome (ACS) is a scoring system used to stratify the risk of bleeding in patients with NSTE-ACS (Non-ST Elevation Acute Coronary Syndrome) in relation to the use of anti-thrombotics. CRUSADE bleeding score was developed and validated in a large community-treated NSTEMI patients. Clinical trials involving almost 48.000 patients with NSTEMI have demonstrated that major bleeding is associated with a 5-fold increase in 30-day mortality. This makes bleeding-risk stratification is a routine part in NSTE-ACS patients investigation. Download "CRUSADE Risk Score for ACS: Cardiology Calculator" app now!
Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "CRUSADE Risk Score for ACS: Cardiology Calculator" app might be different with your local practice. Consult to expert doctor whenever necessary.
Why should you choose "CRUSADE Risk Score for ACS: Cardiology Calculator"?
- Simple and very easy to use.
- Define the importance of CRUSADE bleeding risk stratification
- Accurately scoring all the variables needed
- Thorough interpretation of the bleeding risk for every patient
- Calculates not only the risk of major bleeding in general non-ST elevation acute coronary syndrome (NSTE-ACS) patients but also the relation to the number of anti-thrombotics used and the relation to the treatment approach (whether it will be conservative or interventional)
- It is totally free. Download now!
CRUSADE Risk Score for acute coronary syndrome (ACS) is a scoring system used to stratify the risk of bleeding in patients with NSTE-ACS (Non-ST Elevation Acute Coronary Syndrome) in relation to the use of anti-thrombotics. CRUSADE bleeding score was developed and validated in a large community-treated NSTEMI patients. Clinical trials involving almost 48.000 patients with NSTEMI have demonstrated that major bleeding is associated with a 5-fold increase in 30-day mortality. This makes bleeding-risk stratification is a routine part in NSTE-ACS patients investigation. Download "CRUSADE Risk Score for ACS: Cardiology Calculator" app now!
Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "CRUSADE Risk Score for ACS: Cardiology Calculator" app might be different with your local practice. Consult to expert doctor whenever necessary.
Latest updates
3.1
Fix several bugs and improve performance